Search for:

Baker McKenzie was invited again to serve as the global editor of the Chambers Life Sciences Practice Guide, which features 19 jurisdictions. This is the sixth consecutive year the Firm has provided its expertise and insight to the annual guide, which offers commentary on a wide range of legal and business issues in major healthcare and life sciences markets.

The reader may welcome the fact that, against a general trend to have increasingly more narrowly defined international guides, the legal content of this publication encompasses two related yet very different sectors of life sciences: medicines and medical devices. This makes it the most complete publication right now, covering all the main aspects of the life cycle of medical products.

Chair of the Global Healthcare & Life Sciences Industry Group Vanina Caniza, as well as partners Christian López-SilvaRoel Meers and Elisabeth White, co-authored the global introduction of the guide. The introduction discusses the emerging trends and strategic imperatives driving the highly regulated life sciences sector, including the rise of digital health solutions, licensing and collaboration agreements and tech M&A. It also features insights pertaining to supply chains, emerging ESG considerations, medical cannabis, IP risks and more.

The guide provides the latest developments and updates to in-house counsel and business executives on: regulations and compliance; clinical trials; marketing, manufacturing and distribution of pharmaceuticals and medical devices; pricing; digital health; patents; and COVID-19.

At the same time, the Firm also authored national chapters in four jurisdictions:


*Trench Rossi Watanabe and Baker McKenzie have executed a strategic cooperation agreement for consulting on foreign law


Vanina Caniza is a partner in Baker McKenzie’s Buenos Aires office and the Global Chair of the Healthcare & Life Sciences Group. She advises a range of multinational, Latin America and Argentine clients in a variety of corporate and commercial law matters, with extensive experience in corporate compliance, commercial agreements, mergers & acquisitions and regulatory advice. Vanina has extensive knowledge in the pharmaceutical, biotech and medical device sectors. She completed postgraduate courses on Biotechnology at Universidad Torcuato di Tella (Buenos Aires) and on Health Law at Universidad de Buenos Aires. She was previously the Latin America Leader of the Healthcare & Life Sciences Group and also sits on the Steering Committee of the Firm’s Latin America Corporate Compliance Group. She is currently a professor in the CEC Compliance & Ethics Certification (AAEC-UCEMA).


Christian is the head of Healthcare & Life Sciences Industry Group in Mexico, as well as a member of the Steering Committee of the North American and Latin America Healthcare Group. He has more than 17 years of experience in regulation of life sciences, pharmaceutical law and biotechnology matters, having worked in the private and public sectors and at the national and international level. For several consecutive years, Christian has led the rankings for Life Sciences both nationally (Chambers Latin America) and internationally (Chambers Global).

Write A Comment